<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28973533</article-id>
<article-id pub-id-type="pmc">5886282</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddx311</article-id>
<article-id pub-id-type="publisher-id">ddx311</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Prader-Willi syndrome proteins MAGEL2 and necdin regulate leptin receptor cell surface abundance through ubiquitination pathways</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wijesuriya</surname>
<given-names>Tishani Methsala</given-names>
</name>
<xref ref-type="aff" rid="ddx311-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>De Ceuninck</surname>
<given-names>Leentje</given-names>
</name>
<xref ref-type="aff" rid="ddx311-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Masschaele</surname>
<given-names>Delphine</given-names>
</name>
<xref ref-type="aff" rid="ddx311-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sanderson</surname>
<given-names>Matthea R</given-names>
</name>
<xref ref-type="aff" rid="ddx311-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carias</surname>
<given-names>Karin Vanessa</given-names>
</name>
<xref ref-type="aff" rid="ddx311-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tavernier</surname>
<given-names>Jan</given-names>
</name>
<xref ref-type="aff" rid="ddx311-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wevrick</surname>
<given-names>Rachel</given-names>
</name>
<xref ref-type="aff" rid="ddx311-aff1">1</xref>
<xref ref-type="corresp" rid="ddx311-cor1"></xref>
<!--<email>rwevrick@ualberta.ca</email>-->
</contrib>
</contrib-group>
<aff id="ddx311-aff1">
<label>1</label>Department of Medical Genetics, University of Alberta, Edmonton T6G 2H7, Canada</aff>
<aff id="ddx311-aff2">
<label>2</label>Department of Biochemistry, VIB Center for Medical Biotechnology and Faculty of Medicine and Health Sciences, Ghent University, B-9000 Ghent, Belgium</aff>
<author-notes>
<corresp id="ddx311-cor1"><label>*</label>To whom correspondence should be addressed. Tel: +1 7804927908; Fax: +1 7804921998; Email: <email>rwevrick@ualberta.ca</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date iso-8601-date="2017-08-14" pub-type="epub">
<day>14</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>11</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>26</volume>
<issue>21</issue>
<fpage>4215</fpage>
<lpage>4230</lpage>
<history>
<date date-type="received">
<day>12</day>
<month>5</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>24</day>
<month>7</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>1</day>
<month>8</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri xlink:href="ddx311.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>In Prader-Willi syndrome (PWS), obesity is caused by the disruption of appetite-controlling pathways in the brain. Two PWS candidate genes encode MAGEL2 and necdin, related melanoma antigen proteins that assemble into ubiquitination complexes. Mice lacking <italic>Magel2</italic> are obese and lack leptin sensitivity in hypothalamic pro-opiomelanocortin neurons, suggesting dysregulation of leptin receptor (LepR) activity. Hypothalamus from <italic>Magel2</italic>-null mice had less LepR and altered levels of ubiquitin pathway proteins that regulate LepR processing (Rnf41, Usp8, and Stam1). MAGEL2 increased the cell surface abundance of LepR and decreased their degradation. LepR interacts with necdin, which interacts with MAGEL2, which complexes with RNF41 and USP8. Mutations in the MAGE homology domain of MAGEL2 suppress RNF41 stabilization and prevent the MAGEL2-mediated increase of cell surface LepR. Thus, MAGEL2 and necdin together control LepR sorting and degradation through a dynamic ubiquitin-dependent pathway. Loss of MAGEL2 and necdin may uncouple LepR from ubiquitination pathways, providing a cellular mechanism for obesity in PWS.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Canadian Institutes of Health Research</named-content>
<named-content content-type="funder-identifier">10.13039/501100000024</named-content>
</funding-source>
<award-id>MOP 130367</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">European Research Council</named-content>
<named-content content-type="funder-identifier">10.13039/100010663</named-content>
</funding-source>
<award-id>CYRE, N°340941</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="16"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>